-
1
-
-
1042302005
-
The STATs of cancer: New molecular targets come of age
-
10.1038/nrc1275
-
Yu H, Jove R (2004) The STATs of cancer: new molecular targets come of age. Nat Rev Cancer 4:450-456
-
(2004)
Nat Rev Cancer
, vol.4
, pp. 450-456
-
-
Yu, H.1
Jove, R.2
-
2
-
-
0026770248
-
Interferon-dependent tyrosine phosphorylation of a latent cytoplasmic transcription factor
-
1496401 10.1126/science.1496401 1:CAS:528:DyaK38XlsV2jurs%3D
-
Schindler C, Shuai K, Prezioso VR, Darnell JE Jr (1992) Interferon-dependent tyrosine phosphorylation of a latent cytoplasmic transcription factor. Science 257:809-813
-
(1992)
Science
, vol.257
, pp. 809-813
-
-
Schindler, C.1
Shuai, K.2
Prezioso, V.R.3
Darnell Jr., J.E.4
-
3
-
-
0036782706
-
Transcription factors as targets for cancer therapy
-
12360277 10.1038/nrc906 1:CAS:528:DC%2BD38XnsVGrtbo%3D
-
Darnell JE Jr (2002) Transcription factors as targets for cancer therapy. Nat Rev Cancer 2:740-749
-
(2002)
Nat Rev Cancer
, vol.2
, pp. 740-749
-
-
Darnell Jr., J.E.1
-
4
-
-
0034657336
-
The role of STATs in transcriptional control and their impact on cellular function
-
10851045 10.1038/sj.onc.1203476 1:CAS:528:DC%2BD3cXktVGhsb4%3D
-
Bromberg J, Darnell JE Jr (2000) The role of STATs in transcriptional control and their impact on cellular function. Oncogene 19:2468-2473
-
(2000)
Oncogene
, vol.19
, pp. 2468-2473
-
-
Bromberg, J.1
Darnell Jr., J.E.2
-
5
-
-
0013689209
-
Requirement of Stat3 but not Stat1 activation for epidermal growth factor receptor-medicated cell growth in vitro
-
9769331 10.1172/JCI3785 1:CAS:528:DyaK1cXmsFOrs74%3D
-
Grandis J, Drenning SD, Chakraborty A, Zhou MY, Zeng Q, Pitt AS, Tweardy DJ (1998) Requirement of Stat3 but not Stat1 activation for epidermal growth factor receptor-medicated cell growth in vitro. J Clin Investig 102:1385-1392
-
(1998)
J Clin Investig
, vol.102
, pp. 1385-1392
-
-
Grandis, J.1
Drenning, S.D.2
Chakraborty, A.3
Zhou, M.Y.4
Zeng, Q.5
Pitt, A.S.6
Tweardy, D.J.7
-
6
-
-
0037699512
-
Activation of Stat3 by receptor tyrosine kinases and cytokines regulates survival in human non-small-cell carcinoma cells
-
12833138 10.1038/sj.onc.1206479 1:CAS:528:DC%2BD3sXkvFSkur8%3D
-
Song L, Turkson J, Karras JG, Jove R, Haura EB (2003) Activation of Stat3 by receptor tyrosine kinases and cytokines regulates survival in human non-small-cell carcinoma cells. Oncogene 22:4150-4165
-
(2003)
Oncogene
, vol.22
, pp. 4150-4165
-
-
Song, L.1
Turkson, J.2
Karras, J.G.3
Jove, R.4
Haura, E.B.5
-
7
-
-
33748992592
-
Signal transducers and activators of transcription 3 pathway activation in drug-resistant ovarian cancer
-
16951221 10.1158/1078-0432.CCR-06-0861 1:CAS:528:DC%2BD28XovF2hu7s%3D
-
Duan Z, Foster R, Bell DA, Mahoney J, Wolak K, Vaidya A, Hampel C, Lee H, Seiden MV (2006) Signal transducers and activators of transcription 3 pathway activation in drug-resistant ovarian cancer. Clin Cancer Res 12:5055-5063
-
(2006)
Clin Cancer Res
, vol.12
, pp. 5055-5063
-
-
Duan, Z.1
Foster, R.2
Bell, D.A.3
Mahoney, J.4
Wolak, K.5
Vaidya, A.6
Hampel, C.7
Lee, H.8
Seiden, M.V.9
-
8
-
-
0030772458
-
STAT3 serine phosphorylation by ERK-dependent and -independent pathways negatively modulates its tyrosine phosphorylation
-
9343414 1:CAS:528:DyaK2sXntVSgtrY%3D
-
Chung J, Uchida E, Grammer TC, Blenis J (1997) STAT3 serine phosphorylation by ERK-dependent and -independent pathways negatively modulates its tyrosine phosphorylation. Mol Cell Biol 17:6508-6516
-
(1997)
Mol Cell Biol
, vol.17
, pp. 6508-6516
-
-
Chung, J.1
Uchida, E.2
Grammer, T.C.3
Blenis, J.4
-
9
-
-
47649105292
-
Cardiac hormones and urodilatin eliminate up to 86 % of human small-cell lung carcinomas in mice
-
10.1111/j.1365-2362.2008.01978.x 1:CAS:528:DC%2BD1cXhtVOnu7nP
-
Eichelbaum EJ, Sun Y, Alli AA, Gower WR Jr, Vesely DL (2008) Cardiac hormones and urodilatin eliminate up to 86 % of human small-cell lung carcinomas in mice. Eur J Clin Investig 38:562-570
-
(2008)
Eur J Clin Investig
, vol.38
, pp. 562-570
-
-
Eichelbaum, E.J.1
Sun, Y.2
Alli, A.A.3
Gower Jr., W.R.4
Vesely, D.L.5
-
10
-
-
34250172696
-
Elimination of up to 80 % of human pancreatic adenocarcinomas in athymic mice by cardiac hormones
-
17591353 1:CAS:528:DC%2BD2sXnsVSjs70%3D
-
Vesely DL, Eichelbaum EJ, Sun Y, Alli AA, Vesely BA, Luther SL, Gower WR Jr (2007) Elimination of up to 80 % of human pancreatic adenocarcinomas in athymic mice by cardiac hormones. In Vivo 21:445-452
-
(2007)
Vivo
, vol.21
, pp. 445-452
-
-
Vesely, D.L.1
Eichelbaum, E.J.2
Sun, Y.3
Alli, A.A.4
Vesely, B.A.5
Luther, S.L.6
Gower Jr., W.R.7
-
11
-
-
37349091248
-
Four cardiac hormones eliminate up to two-thirds of human breast cancers in athymic mice
-
18210743 1:CAS:528:DC%2BD1cXkvVagsA%3D%3D
-
Vesely DL, Vesely BA, Eichelbaum EJ, Sun Y, Alli AA, Gower WR Jr (2007) Four cardiac hormones eliminate up to two-thirds of human breast cancers in athymic mice. In Vivo 21:973-978
-
(2007)
Vivo
, vol.21
, pp. 973-978
-
-
Vesely, D.L.1
Vesely, B.A.2
Eichelbaum, E.J.3
Sun, Y.4
Alli, A.A.5
Gower Jr., W.R.6
-
12
-
-
33750741904
-
Vessel dilator and kaliuretic peptide inhibit activation of ERK 1/2 in human prostate cancer cells
-
17094432 1:CAS:528:DC%2BD28Xht1ers7nN
-
Sun Y, Eichelbaum EJ, Wang H, Vesely DL (2006) Vessel dilator and kaliuretic peptide inhibit activation of ERK 1/2 in human prostate cancer cells. Anticancer Res 26:3217-3222
-
(2006)
Anticancer Res
, vol.26
, pp. 3217-3222
-
-
Sun, Y.1
Eichelbaum, E.J.2
Wang, H.3
Vesely, D.L.4
-
13
-
-
33845930794
-
Atrial natriuretic peptide and long acting natriuretic peptide inhibit ERK 1/2 in prostate cancer cells
-
17201125 1:CAS:528:DC%2BD2sXpslChtA%3D%3D
-
Sun Y, Eichelbaum EJ, Wang H, Vesely DL (2006) Atrial natriuretic peptide and long acting natriuretic peptide inhibit ERK 1/2 in prostate cancer cells. Anticancer Res 26:4143-4148
-
(2006)
Anticancer Res
, vol.26
, pp. 4143-4148
-
-
Sun, Y.1
Eichelbaum, E.J.2
Wang, H.3
Vesely, D.L.4
-
14
-
-
64949193847
-
Insulin and epidermal growth factor activation of ERK 1/2 and DNA synthesis is inhibited by four cardiac hormones
-
1:CAS:528:DC%2BD2sXhtValu7zF
-
Sun Y, Eichelbaum EJ, Wang H, Vesely DL (2007) Insulin and epidermal growth factor activation of ERK 1/2 and DNA synthesis is inhibited by four cardiac hormones. J Cancer Mol 3(4):113-120
-
(2007)
J Cancer Mol
, vol.3
, Issue.4
, pp. 113-120
-
-
Sun, Y.1
Eichelbaum, E.J.2
Wang, H.3
Vesely, D.L.4
-
15
-
-
64949135331
-
Vessel dilator and kaliuretic peptide inhibit Ras in human prostate cancer cells
-
19414334 1:CAS:528:DC%2BD1MXltFChtLk%3D
-
Sun Y, Eichelbaum EJ, Skelton WP IV, Lenz A, Regales N, Wang H, Vesely DL (2009) Vessel dilator and kaliuretic peptide inhibit Ras in human prostate cancer cells. Anticancer Res 29:971-975
-
(2009)
Anticancer Res
, vol.29
, pp. 971-975
-
-
Sun, Y.1
Eichelbaum, E.J.2
Skelton, I.V.W.P.3
Lenz, A.4
Regales, N.5
Wang, H.6
Vesely, D.L.7
-
16
-
-
67650925065
-
Atrial natriuretic peptide and long-acting natriuretic peptide inhibit Ras in human prostate cancer cells
-
19528444 1:CAS:528:DC%2BD1MXos1Wnurk%3D
-
Sun Y, Eichelbaum EJ, Lenz A, Skelton WP IV, Wang H, Vesely DL (2009) Atrial natriuretic peptide and long-acting natriuretic peptide inhibit Ras in human prostate cancer cells. Anticancer Res 29:1889-1893
-
(2009)
Anticancer Res
, vol.29
, pp. 1889-1893
-
-
Sun, Y.1
Eichelbaum, E.J.2
Lenz, A.3
Skelton, I.V.W.P.4
Wang, H.5
Vesely, D.L.6
-
17
-
-
34249288341
-
Vessel dilator and kaliuretic peptide inhibit MEK 1/2 activation in human prostate cancer cells
-
17595752 1:CAS:528:DC%2BD2sXmsFygurc%3D
-
Sun Y, Eichelbaum EJ, Wang H, Vesely DL (2007) Vessel dilator and kaliuretic peptide inhibit MEK 1/2 activation in human prostate cancer cells. Anticancer Res 27:1387-1392
-
(2007)
Anticancer Res
, vol.27
, pp. 1387-1392
-
-
Sun, Y.1
Eichelbaum, E.J.2
Wang, H.3
Vesely, D.L.4
-
18
-
-
37349025338
-
Atrial natriuretic peptide and long acting natriuretic peptide inhibit MEK 1/2 activation in human prostate cancer cells
-
18225537 1:CAS:528:DC%2BD1cXlslaluw%3D%3D
-
Sun Y, Eichelbaum EJ, Wang H, Vesely DL (2007) Atrial natriuretic peptide and long acting natriuretic peptide inhibit MEK 1/2 activation in human prostate cancer cells. Anticancer Res 27:3813-3818
-
(2007)
Anticancer Res
, vol.27
, pp. 3813-3818
-
-
Sun, Y.1
Eichelbaum, E.J.2
Wang, H.3
Vesely, D.L.4
-
19
-
-
84866275052
-
Novel dual inhibitors of vascular endothelial growth factor and the VEGFR2 receptor
-
10.1111/j.1365-2362.2012.02695.x
-
Nguyen JP, Frost CD, Lane ML, Skelton WP IV, Skelton M, Vesely DL (2012) Novel dual inhibitors of vascular endothelial growth factor and the VEGFR2 receptor. Eur J Clin Investig. doi: 10.1111/j.1365-2362.2012.02695.x
-
(2012)
Eur J Clin Investig
-
-
Nguyen, J.P.1
Frost, C.D.2
Lane, M.L.3
Skelton, I.V.W.P.4
Skelton, M.5
Vesely, D.L.6
|